Nuplazid

6 Drugs Approved Despite Failed Trials or Minimal Data
BioSpace
Mon, 10/9/23 - 11:10 am
Ipsen
Sohonos
Sarepta Therapeutics
Elevidys
Biogen
Qalsody
Eisai
Aduhelm
Jazz Pharma
PharmaMar
Zepzelca
Acadia Pharma
Nuplazid
Acadia hits another Nuplazid roadblock as the FDA doles out CRL and recommends another trial
Endpoints
Fri, 08/5/22 - 10:51 am
Acadia Pharmaceuticals
Nuplazid
FDA
complete response letter
Alzheimer's disease psychosis
Acadia's Alzheimer’s Drug Voted Down by FDA Advisory Committee
BioSpace
Mon, 06/20/22 - 10:30 am
Acadia Pharmaceuticals
Nuplazid
FDA
Alzheimer's disease
A year after CRL, Acadia is going back to bat for Nuplazid at the FDA
Endpoints
Mon, 05/2/22 - 06:15 pm
Acadia Pharmaceuticals
FDA
Nuplazid
Alzheimer's disease psychosis
FDA panel to review once-rejected Acadia drug for psychosis
BioPharma Dive
Thu, 03/10/22 - 10:23 pm
Acadia Pharmaceuticals
FDA
Nuplazid
Alzheimer's disease psychosis
Acadia slims Nuplazid label expansion bid in hopes of clinching Alzheimer's dementia nod without extra studies
Fierce Pharma
Tue, 12/21/21 - 10:18 am
Acadia Pharmaceuticals
Nuplazid
dementia
Alzheimer's disease psychosis
Three Pharma Companies Seek to Address FDA Rejections
BioSpace
Wed, 11/17/21 - 11:50 pm
FDA
Iterum
sulopenem
Eton Pharmaceuticals
Acadia Pharmaceuticals
Nuplazid
FDA rejects Acadia’s bid for Nuplazid approval in dementia-related psychosis
MedCity News
Mon, 04/5/21 - 02:37 pm
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
FDA
Acadia's surprise Nuplazid snag—and subsequent cold shoulder at FDA—beg more questions than answers
Fierce Pharma
Wed, 03/10/21 - 11:17 am
Acadia Pharmaceuticals
FDA
Nuplazid
Parkinson's Disease Psychosis
Acadia fails in attempt to expand use of antipsychotic to treat patients with depression
Stat
Mon, 07/20/20 - 11:54 pm
Acadia Pharma
clinical trials
major depression
Nuplazid
major depressive disorder
antipsychotics
Fresh off positive Nuplazid data, Acadia adds new clinical drug from Vanderbilt in milestone-heavy deal
Endpoints
Fri, 05/8/20 - 10:43 am
Acadia Pharma
Vanderbilt
Nuplazid
drug development
Alzheimer's disease
Parkinson's Disease
3 Biotech Stocks That Soared Last Week
Motley Fool
Sun, 09/15/19 - 09:51 pm
Acadia Pharmaceuticals
Nuplazid
Mesoblast
Grunenthal
MPC-06-ID
Kodiak Sciences
age-related macular degeneration
Acadia calls early halt to Nuplazid psychosis trial after promising interim results
Fierce Pharma
Tue, 09/10/19 - 11:41 pm
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
Trial win could drive Acadia's Nuplazid to new use
Biopharma Dive
Mon, 09/9/19 - 08:00 pm
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
clinical trials
FDA
Acadia drops after hours on Phase III miss for schizophrenia
BioCentury
Mon, 07/22/19 - 11:08 pm
Acadia
Nuplazid
schizophrenia
clinical trials
Upcoming events – Acadia hopes for new indications for Nuplazid
EP Vantage
Fri, 05/3/19 - 10:18 am
Acadia Pharmaceuticals
antipsychotics
Nuplazid
schizophrenia
dementia
Justice Department launches probe into Acadia's Nuplazid marketing
Fierce Pharma
Mon, 03/11/19 - 11:45 am
Acadia Pharmaceuticals
Nuplazid
DOJ
drug marketing
Acadia Pharma Soars After FDA Investigation Clears Nuplazid of Additional Safety Problems
BioSpace
Fri, 09/21/18 - 11:25 am
Acadia
FDA
Nuplazid
Parkinson's Disease Psychosis
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
CP Wire
Mon, 09/10/18 - 11:43 am
Acadia
Nuplazid
pimavanserin
dementia-related psychosis
Parkinson's Disease Psychosis
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
Mon, 09/10/18 - 09:53 am
Acadia
Nuplazid
pimavanserin
dementia-related psychosis

Pages